Adtalem Global Education Stock: Business Model, Growth Drivers, and Key Investor Considerations for
Adtalem Global Education is a key player in for-profit higher education, focusing on healthcare and professional training. The company utilizes a diversified portfolio of institutions like Chamberlain University, Walden University, and Medical Education Technologies Inc. to cater to high-demand fields such as nursing and medicine. Its business model emphasizes flexible online and hybrid learning, positive student outcomes, and strategic growth drivers, making it an appealing option for North American investors seeking stable growth in the education sector despite regulatory risks and competition.
Adtalem Global Education Stock: Business Model, Growth Drivers, and Key Investor Considerations for
Adtalem Global Education (ATGE) is a key player in for-profit higher education, focusing on healthcare and professional training through institutions like Chamberlain University and Walden University. The company's business model thrives on strong demand in healthcare sectors, especially nursing, and aims for stable growth by adapting to evolving enrollment trends and maintaining a diversified portfolio. Key investor considerations include its strong market position in high-demand fields, strategic initiatives for growth, solid financial health, and an attractive proposition for North American investors, despite regulatory risks and competition.
Adtalem Global Education Experiences Revision in Stock Evaluation Amid Market Dynamics
Adtalem Global Education (ATGE) has recently seen a stock price adjustment to $114.61, experiencing significant volatility over the past year with a 52-week high of $156.26 and a low of $87.00. Despite a mixed technical summary, including a mildly bullish MACD weekly and bearish moving averages daily, the company has consistently outperformed the S&P 500 across various time frames. Over the last three years, Adtalem's stock soared by 204.17%, demonstrating strong resilience and adaptability in the market.
Adtalem Global Education (NYSE:CVSA) Rating Lowered to Hold at Zacks Research
Zacks Research downgraded Adtalem Global Education (NYSE:CVSA) from a "strong-buy" to a "hold" rating. The company reported quarterly EPS of $2.43 on $503.39 million in revenue, with a net margin of 13.41% and ROE of 20.24%. Insider buying activity has been noted, with Director Michael W. Malafronte purchasing 8,890 shares and total insider acquisitions totaling 37,236 shares valued at approximately $3.75 million over the past 90 days.
Nursing, health care school leases full floor in Greater Cincinnati office tower
Covista's Chamberlain University is set to open a new nursing and health care school in a suburban Cincinnati office tower. The new campus, located in the Kenwood Collection, will accommodate 450 students. This move signifies an expansion of health care education opportunities in the Greater Cincinnati area.
Adtalem Global Education (ATGE) Price Target Increased by 12.64% to 174.93
The price target for Adtalem Global Education (ATGE) has been increased by 12.64% to $174.93. This adjustment reflects a significant positive outlook for the company's stock. Investors and market watchers should note this revised target.
Adtalem Global Education (ATGE) Q2 earnings and revenues top estimates
Adtalem Global Education (ATGE) reported its Q2 earnings and revenues, surpassing analyst estimates. This positive financial performance indicates a strong quarter for the education company.
ATGE SEC Filings - Adtalem Global Ed Inc 10-K, 10-Q, 8-K Forms
This page provides access to U.S. Securities and Exchange Commission filings for Adtalem Global Education Inc. (NYSE: ATGE), including 10-K, 10-Q, 8-K, and Form 4 documents. These filings offer detailed information on the company's operations, financial condition, governance, and insider activities, with AI-powered summaries to highlight key points. Recent filings cover share repurchase authorizations, quarterly financial results, executive changes, and insider trading disclosures related to stock payouts and tax withholdings.
Adtalem Global Education Inc. (NYSE:ATGE) Given Consensus Recommendation of "Moderate Buy" by Analysts
Adtalem Global Education Inc. (NYSE:ATGE) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month target price of $151.50. The company recently reported strong quarterly earnings, beating EPS estimates by $0.24 and showing a 12.4% year-over-year revenue increase, while also setting an optimistic FY2026 EPS guidance. Despite a significant difference between its current stock price and analyst targets, institutional investors hold a substantial stake in the company.
Covista Rebrand Pairs New Ticker With Three Year Growth Targets
Covista Inc., formerly Adtalem Global Education Inc., has completed a rebrand, adopted the new ticker NYSE:CVSA, and introduced a three-year growth plan to address the U.S. healthcare workforce shortage. The company reaffirmed its 2026 revenue guidance of US$1.9 billion to US$1.94 billion and outlined growth targets through 2029, emphasizing operational excellence, platform expansion, employer integration, and technology to scale its healthcare education programs. Investors are advised to monitor execution risks, competitive landscape, and the alignment of reported revenues with the stated financial roadmap and growth targets.
Reprint-CB24147AdtalemGlobal
Steve Beard, president and CEO of Adtalem Global Education, has been named chairman of the board, succeeding Michael W. Malafronte. This decision follows a period of positive developments for Adtalem, including a significant office expansion into Willis Tower and raised earnings guidance. Beard's leadership is credited with the company's focus on healthcare education, leading to substantial enrollment growth and an increased role in addressing healthcare labor shortages.
ATGE Earning Date, Earning Analysis and Earning Prediction
This article provides an earnings analysis and prediction for ATGE, including past quarterly results and future forecasts. It highlights analyst projections for 2026/Q3 revenue and EPS, noting recent estimate revisions and their correlation with stock price movements. The article also includes a historical analysis of ATGE's stock price reaction before and after earnings reports.
Neumeier Poma Investment Counsel LLC Trims Stock Position in Adtalem Global Education Inc. $ATGE
Neumeier Poma Investment Counsel LLC reduced its stake in Adtalem Global Education Inc. (NYSE:ATGE) by 17.4% in the third quarter, selling 67,583 shares and retaining 320,477 shares valued at $49.5 million. Adtalem Global Education recently exceeded quarterly expectations with EPS of $2.43 and revenue of $503.4 million, setting FY 2026 EPS guidance between $7.80 and $8.00. Analysts currently give the stock a "Moderate Buy" rating with an average target price of $151.50.
Adtalem Global Education Inc. $ATGE Shares Bought by Thornburg Investment Management Inc.
Thornburg Investment Management Inc. increased its stake in Adtalem Global Education Inc. (NYSE:ATGE) by 19.4% in the third quarter, acquiring an additional 20,257 shares to hold a total of 124,872 shares valued at approximately $19.29 million. Adtalem Global Education reported strong quarterly earnings, beating analyst expectations with an EPS of $2.43 and revenue of $503.4 million, and maintains a "Moderate Buy" consensus rating among analysts with an average price target of $151.50. Other institutional investors have also adjusted their positions in the company, which continues to trade at a P/E ratio of 14.47 and has a market capitalization of $3.40 billion.
49,662 Shares in Adtalem Global Education Inc. $ATGE Purchased by Lansforsakringar Fondforvaltning AB publ
Lansforsakringar Fondforvaltning AB publ recently acquired 49,662 shares of Adtalem Global Education Inc. (NYSE:ATGE), valued at approximately $7.67 million, now holding about 0.14% of the company. Adtalem Global Education reported strong Q3 earnings, beating analyst expectations with $2.43 EPS and $503.39 million in revenue, and set a positive FY2026 EPS guidance. The stock currently has a "Moderate Buy" consensus rating with a target price of $151.50, despite recent trading near $98.54.
Trading the Move, Not the Narrative: (ATGE) Edition
This article provides an AI-driven analysis for Adtalem Global Education Inc. (NASDAQ: ATGE), highlighting divergent sentiment and a mid-channel oscillation pattern. It presents three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels, and offers AI-generated signals and multi-timeframe analysis for institutional-grade insights.
More veterinary colleges in line for accreditation evaluations
The AVMA Council on Education has scheduled 14 site visits this year, including five consultative visits to new veterinary programs seeking accreditation. These visits are a crucial step for programs like Rowan University, Clemson University, Arkansas State University, Chamberlain University, University of Maryland Eastern Shore, Rocky Vista University, and Hanover College to receive a letter of reasonable assurance, which allows them to enroll students while working towards full accreditation. This expansion reflects a growing need for veterinary professionals and diverse educational opportunities within the field.
SG Capital Management LLC Sells 47,620 Shares of Adtalem Global Education Inc. $ATGE
SG Capital Management LLC reduced its stake in Adtalem Global Education Inc. by 38.5%, selling 47,620 shares and retaining 76,056 shares valued at $11.75 million, which now represents 1.0% of its portfolio. Adtalem reported a strong quarter with EPS of $2.43 against an expected $2.19 and revenue of $503.4 million, also providing optimistic FY2026 EPS guidance. The stock holds a "Moderate Buy" consensus rating with a $151.50 average target price, despite mixed recent analyst actions including a downgrade by Weiss and positive notes from BMO, Baird, and Barrington.
Covista Name Change Puts Focus On Governance And Future Priorities
Adtalem Global Education Inc. (NYSE:ATGE) has officially changed its corporate name to Covista Inc., with the rebranding reflected in updated corporate documents. This move is presented as an administrative decision by the board, rather than an immediate shift in strategy or leadership. Investors are advised to monitor future communications for insights into Covista's priorities and how the new identity aligns with its long-term objectives in the evolving education sector.
New Ross Med dean will lead school graduating most U.S. M.D.s
Covista (NYSE: ATGE) has appointed Cheryl Holmes, M.D., as the new dean of Ross University School of Medicine (RUSM), effective March 16. Dr. Holmes brings over 30 years of clinical and academic leadership experience, and her appointment aims to strengthen RUSM's role in addressing the healthcare workforce shortage. RUSM is noted for graduating more M.D.s than any other U.S. medical school and achieving a 96% first-time residency attainment rate for its 2024-2025 graduates.
Possible Bearish Signals With Adtalem Global Education Insiders Disposing Stock
Over the last year, insiders at Adtalem Global Education (NYSE:ATGE) have sold a substantial amount of stock, totaling US$9.6 million, significantly more than the US$229k they purchased. While a major sale by a director at the current price raises some caution, recent insider purchases totaling US$142k suggest some confidence. Despite the overall net selling, high insider ownership of 2.4% indicates good alignment with shareholders.
Covista Name Change Puts Focus On Governance And Future Priorities
Adtalem Global Education Inc. has officially changed its corporate name to Covista Inc. (NYSE:ATGE), a move formalized through amendments to corporate documents. While this rebranding primarily signifies an administrative update in governance, it also presents an opportunity for the company to articulate new priorities and strategies in the evolving education sector. Investors are advised to monitor future communications for insights into how this new identity aligns with Covista's strategic direction and capital allocation plans.
Why Adtalem Global Education (ATGE) is a Top Value Stock for the Long-Term
This article highlights Adtalem Global Education (ATGE) as a top value stock for long-term investment. It suggests that interested investors can access further recommendations and free stock analysis from Zacks Investment Research. The content was originally published on Zacks.com.
Is Covista’s (ATGE) Rebrand the Missing Link in Its Healthcare Education Competitive Edge?
Covista Inc., formerly Adtalem Global Education Inc., has rebranded to focus on healthcare education, including AI credentials and workforce support, to address staffing gaps. The rebranding underlines a shift to a singular healthcare identity, with a partnership with Google Cloud for AI credentials being a significant component of its investment narrative. While the rebranding is largely cosmetic, the company's focus on healthcare and execution on enrollment, margins, and buyback authorization, along with managing regulatory risks, remain key factors for its investment appeal.
Public Sector Pension Investment Board Boosts Stock Holdings in Adtalem Global Education Inc. $ATGE
The Public Sector Pension Investment Board increased its stake in Adtalem Global Education (NYSE:ATGE) by 11.8% in Q3, now owning 157,012 shares valued at $24.25 million. Analysts have provided mixed signals; while Zacks upgraded long-term EPS forecasts, some near-term estimates were trimmed, and the stock was labeled oversold. Adtalem recently surpassed quarterly earnings and revenue expectations and provided strong FY2026 guidance.
Down 20.9% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround
Adtalem Global Education (ATGE) has experienced a significant 20.9% decline in its stock price over the past month. However, the stock now appears oversold with an RSI reading of 29.18, suggesting a potential for reversal. This technical indicator, combined with rising earnings estimates from analysts and a Zacks Rank #2 (Buy), indicates that ATGE could be poised for a near-term turnaround.
LSV Asset Management Lowers Stake in Adtalem Global Education Inc. $ATGE
LSV Asset Management has reduced its stake in Adtalem Global Education Inc. (NYSE:ATGE) by 5.8% in the third quarter of 2025, selling 32,200 shares and now owning 521,800 shares valued at approximately $80.59 million. Despite this, Adtalem Global Education has shown strong financial performance, beating earnings and revenue estimates in its latest quarter and providing a positive EPS guidance for FY2026. Analysts currently hold a "Moderate Buy" consensus rating for the company with an average price target of $151.50.
Cibc World Market Inc. Purchases 27,297 Shares of Adtalem Global Education Inc. $ATGE
Cibc World Market Inc. increased its holdings in Adtalem Global Education Inc. by 28% in the third quarter, acquiring an additional 27,297 shares, bringing its total ownership to 124,867 shares valued at $19.29 million. Other institutional investors like Allspring Global Investments and Goldman Sachs also significantly boosted their stakes. Adtalem Global Education recently beat quarterly earnings expectations with $2.43 EPS and $503.39 million in revenue, and has provided strong FY2026 EPS guidance.
Candriam S.C.A. Sells 58,465 Shares of Adtalem Global Education Inc. $ATGE
Candriam S.C.A. significantly reduced its stake in Adtalem Global Education (ATGE) by 92.9% in Q3, selling 58,465 shares, though other major institutional investors like Allspring and Goldman Sachs increased their holdings. Adtalem Global Education reported strong Q3 earnings, exceeding EPS and revenue expectations, and provided optimistic FY2026 guidance. The stock currently holds a "Moderate Buy" analyst rating with an average target price of $151.50.
(ATGE) Volatility Zones as Tactical Triggers
This article provides an in-depth analysis of Adtalem Global Education Inc. (NASDAQ: ATGE) using AI models to determine tactical triggers and trading strategies. It highlights weak near and mid-term sentiment, a neutral long-term outlook, and presents position trading, momentum breakout, and risk hedging strategies with specific entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal analysis indicating support and resistance levels.
Adtalem Global Education Stock To $124?
Adtalem Global Education (ATGE) stock has recently dropped by 21.8%, but Trefis believes it has a strong chance of rebounding to $124 due to its history of recovery post-dips and its passing of basic financial quality checks. Historically, the stock has shown a median return of 61% within 12 months after similar sharp dips, with a median peak return of 70%. The company demonstrates robust revenue growth, profitability, and a strong balance sheet, suggesting that the current dip may present a buying opportunity.
Covista Reinvents Healthcare Education Amid Workforce Shortage
Covista, formerly Adtalem Global Education, is strategically addressing the severe U.S. healthcare workforce shortage by focusing solely on healthcare education, graduating 24,000 students annually. The company has also partnered with Google Cloud to launch an AI credentials program and is investing in initiatives to support healthcare workers' mental health and career development. Despite policy challenges, Covista remains optimistic about attracting more students due to the high demand for healthcare professionals.
How the largest health-care education company in U.S. is addressing a growing jobs gap
Covista, formerly Adtalem Global Education, is strategically focusing on healthcare education to tackle a significant worker shortage in the U.S. healthcare industry. With over 8.4 million open healthcare jobs, Covista provides a substantial number of graduates annually, including 10% of America's nurses and twice as many MDs as any other institution. The company's rebranding to Covista reflects its commitment to addressing this growing workforce gap, which CEO Steve Beard warns could lead to a "patient care crisis."
How the largest health-care education company in U.S. is addressing a growing jobs gap
Covista (formerly Adtalem Global Education), the largest health-care education company in the U.S., is focusing on addressing a significant worker shortage in the health-care industry. With over 8.4 million open health-care jobs, Covista aims to provide day-one-ready talent and innovate solutions through partnerships and AI programs. Despite challenges like federal student loan changes, the company remains optimistic about meeting the needs of an aging population.
Covista Rebrand Highlights Healthcare Focus Ahead Of Investor Day Plans
Adtalem Global Education Inc. has rebranded as Covista Inc. (NYSE:ATGE), signaling a strategic focus on career-connected healthcare education. This rebrand follows a four-year transformation and aligns the company with the growing demand for healthcare professionals. An upcoming Investor Day will provide further details on Covista's future strategy, capital allocation, and positioning within the healthcare education segment.
Adtalem Global Education's (NYSE:ATGE) Five-year Earnings Growth Trails the 21% YoY Shareholder Returns
Adtalem Global Education (NYSE:ATGE) has seen its share price increase by 163% over the last five years, translating to a 21% annual return for shareholders. However, the company's earnings per share (EPS) grew at a slower rate of 7.5% per year during the same period, suggesting an increased market valuation for the company. Despite a recent 9.6% decline in the last month, the long-term share price performance indicates positive market perception, further supported by insider purchases.
A Look At Adtalem Global Education’s Valuation As It Rebrands To Covista And Highlights Healthcare Focus
Adtalem Global Education (ATGE) is rebranding to Covista, emphasizing a healthcare focus, and analysts believe the stock is undervalued. The company's P/E ratio of 14.2x is below industry averages, and discounted cash flow models suggest a significant undervaluation relative to its estimated fair value of $234.25 per share. Despite mixed recent trading, its strong historical shareholder return and solid earnings suggest potential for growth.
Adtalem Global Education Inc (NYSE:ATGE) Presents a Compelling Value Investment Case
Adtalem Global Education Inc (NYSE:ATGE) is presented as a compelling value investment due to its attractive valuation, solid financial condition, strong earnings, and reasonable expansion prospects. The company's low Price-to-Earnings ratio, robust solvency, high return on invested capital, and projected EPS growth suggest it is undervalued by the market. While investors should consider industry-specific risks, ATGE aligns with key value investing principles, offering a margin of safety.
Will Strong Earnings, Covista Rebrand and Buybacks Change Adtalem Global Education's (ATGE) Narrative?
Adtalem Global Education, soon to be Covista, reported strong quarterly earnings, reiterated its fiscal 2026 revenue outlook, and continued share repurchases. The rebrand signals a focus on healthcare education to address workforce needs, aiming to reshape its investment narrative. While the company reinforces a profitable and capital-disciplined story, investors should consider potential risks like rising capital intensity and its impact on margins and valuation.
Largest US healthcare educator unveils new name, expanded mission
Adtalem Global Education, the largest healthcare educator in the U.S., has rebranded itself as Covista, signifying an expansion of its mission. This change was announced on February 5, 2026, and was reported by Jon Asplund of Crain's Chicago Business. The article briefly mentions other featured stories related to healthcare politics, insurance, and medical devices.
Largest US healthcare educator unveils new name, expanded mission
Adtalem Global Education, the largest U.S. healthcare educator, has changed its name to Covista. This rebranding is accompanied by an expanded mission for the institution. The article was published on February 5, 2026, by Crain's Chicago Business via Modern Healthcare.
Largest health care educator in the U.S. unveils new name, expanded mission
Adtalem Global Education, the largest health care educator in the U.S., has rebranded as Covista, marking a significant step in its transformation into a multi-university network focused on the health care workforce. Covista plans to expand its health care career network and address the critical workforce shortages, especially in nursing and behavioral health, through organic growth, acquisitions, and new research initiatives. The company currently educates nearly 100,000 students and contributes significantly to the health care workforce annually.
Adtalem Global Education Becomes Covista
Adtalem Global Education has rebranded to Covista, signifying its transformation into America's largest healthcare educator focused on addressing the U.S. healthcare workforce crisis. The company, which will trade under the ticker CVSA starting February 24, 2026, also released new research on the healthcare staffing gap and launched "Covista Open Doors," a multi-year initiative to support healthcare career pathways. Covista will discuss its long-term strategy at an Investor Day on February 24.
The Top 5 Analyst Questions From Adtalem's Q4 Earnings Call
Adtalem Global Education (ATGE) reported strong Q4 results with significant enrollment gains at Walden University and Chamberlain, exceeding analyst estimates for revenue, EPS, and EBITDA. The article highlights key analyst questions regarding market share, preparedness for loan cap changes, and enrollment improvement timelines, and discusses future catalysts like new program launches and the Sallie Mae partnership. Despite the positive earnings, the stock saw a dip, prompting a call for investors to evaluate its current buy/sell status.
Earnings call transcript: Adtalem’s Q2 2026 earnings beat expectations
Adtalem Global Education (NYSE:ATGE) exceeded Q2 2026 earnings expectations with an EPS of $2.43 and revenue of $503.4 million, marking a 10.96% surprise in EPS and a 12.4% year-over-year revenue increase. The company raised its full-year adjusted EPS guidance and reported its 10th consecutive quarter of enrollment growth, reaching 97,000 students. Despite these strong financial results, the stock experienced a 6.46% decline in after-hours trading.
3 School Stocks Leveraging AI & Healthcare Demand Amid Headwinds
The Zacks Schools industry faces challenges like a shrinking student base and regulatory oversight but is seeing improved medium-term prospects due to demand for career-oriented education in healthcare and IT. Technology adoption and industry consolidation are key differentiators, with Workforce Pell expansion also supporting enrollment. Three stocks highlighted for growth potential include American Public Education (APEI), Adtalem Global Education (ATGE), and Stride (LRN), all leveraging these trends.
Assessing Adtalem Global Education (ATGE) Valuation After Recent Share Price Pullback
Adtalem Global Education (ATGE) has experienced a recent share price pullback, declining 4% in a day and 12% over the past week, despite strong long-term returns. The company appears undervalued with a P/E ratio of 14.1x compared to peers and an estimated fair P/E of 19.1x, and its shares are trading at a significant discount according to a discounted cash flow model. This analysis suggests ATGE might be a genuine opportunity rather than a market pricing in future growth, though potential shifts in healthcare education demand need consideration.
Adtalem Weighs Enrollment Momentum And Buybacks Against Recent Share Weakness
Adtalem Global Education (NYSE:ATGE) has reported its tenth consecutive quarter of student enrollment growth and authorized a new $750 million share buyback after completing a previous $150 million program. While the company is expanding health system partnerships and integrating AI into its programs, its share price has declined by 14.6% in the past week and 3.3% in the past year, prompting investors to assess current operations against recent market moves. The stock is currently trading significantly below analyst targets and estimated fair value, suggesting potential for closer examination by investors.
Adtalem Global Education Inc (ATGE) Q2 2026 Earnings Call Transcript
Adtalem Global Education Inc. reported its Q2 2026 earnings, marking its 10th consecutive quarter of enrollment growth and raising its adjusted earnings per share guidance to 17-20% growth. The company achieved record enrollments at Walden and Chamberlain, with overall revenue up 12% to $503 million and adjusted EPS increasing 34% to $2.43. Leadership discussed strategies for addressing the healthcare workforce shortage and confirmed their full-year revenue guidance while updating EPS expectations.
Adtalem Global Education Inc (ATGE) Q2 2026 Earnings Call Transcript
Adtalem Global Education Inc. (ATGE) reported its Q2 2026 earnings, marking its 10th consecutive quarter of enrollment growth. The company reaffirmed its full-year revenue guidance of 6% to 8.5% growth and raised its adjusted EPS guidance to 17% to 20% growth, driven by strong performance at Walden and MedVet, despite a temporary pause in enrollment growth at Chamberlain. Leadership also previewed an upcoming Investor Day to discuss multi-year growth frameworks and capacity expansion plans.
